ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

DCE Board Okays Concepts For More Than $6 Million

March 13, 1987

ACS Awards Professorships To Brugge, Hanahan, Samson; Renews Verma, Wigler.

February 9, 2001

NCAB To Hear Program Reviews, Try Again On Act Revisions

October 22, 1976

Cancer Clinical Trials Approved By NCI Last Month Are Listed

November 29, 2002

Barbara Rimer and Owen Witte To Be Named Members Of the President’s Cancer Panel

December 9, 2011

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982